Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Bva02g01813 | ATGGCAGAAGCTGAAGCTAGCAAACATGCTTCTTCTGCAGCCACAgctgcaaataataatattgttcaATCAACCAAACCCAGCACGAGAAGGTTCATTGGGGTGCGGCAAAGGCCTTCGGGGAGGTGGGTAGCTGAGATCAAAGACTCCTCTCAGCACGTGAGGCTATGGCTTGGAACCTACGACACACCAGAAGAAGCAGCCAGGGCTTATGACGAAGCAGCTCGAGCTCTGCGCGGTGAAAATGCACGAACCAATTTCGCCCCTGCCACGAGCCAGTCAGGGTCAGGTCCTTCCAGTGGGTCCGATGGGAGGCATGGTTTGAGCTTTGCTTCCTTGAAAGCCAGGTTAAGCAAGAACCTACAGAGTATCATGGCGAGGGCAAGTGAGACCAAGTCTTCAAAGAGTAGGGTGAGTGATCATTTCACCTTTGCTAGCATATTTCACCGTAATAGGAGCCTCGGCCACAGCCACGGCCAGTATCGAATCCATGCGGATGCAGCCTCGGATGTGGAGAAAGTGGTGCAGCCTAGCATAATAGTCCCTCCTGTTGATCAAACTACTCCTGCAGAGGCTTCAACTTCTTGTTGGGAAACCTCTAGTAGCCTATCTGATTGTAACTCTGACTGGGTCGGGTTCCAGCAATCCGGATTGGATTCAGACGGGTCGGATGTAGGGGAAGTTGGTGTTGGGGAGCAAGGGTTGTTGGAGCAATTGTTGGGGTGGGTGGATAGTCCCGATCATACTAATTGTGCTGGTGGATTAAGTGAAGAGGGTTCAAGGAGTAAGAGATTTAAGGTGTCTTCTTCTGTGCTTGTGCCTCCAACTTTTAGTAATTACTCTGATCATGAGGCTTGTGGCTCTCCTTATCATCATGCTTGTGGGTCACCATATAGTAGTGCTTATTCTTCTCCATACAACAATAATGGTGGTGGGAATTA | 941 | 0.4899 | MAEAEASKHASSAATAANNNIVQSTKPSTRRFIGVRQRPSGRWVAEIKDSSQHVRLWLGTYDTPEEAARAYDEAARALRGENARTNFAPATSQSGSGPSSGSDGRHGLSFASLKARLSKNLQSIMARASETKSSKSRVSDHFTFASIFHRNRSLGHSHGQYRIHADAASDVEKVVQPSIIVPPVDQTTPAEASTSCWETSSSLSDCNSDWVGFQQSGLDSDGSDVGEVGVGEQGLLEQLLGWVDSPDHTNCAGGLSEEGSRSKRFKVSSSVLVPPTFSNYSDHEACGSPYHHACGSPYSSAYSSPYNNNGGGN | 313 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Bva02g01813 | 313 | PANTHER | SHN SHINE , DNA BINDING / TRANSCRIPTION FACTOR | 1 | 258 | - | - | |
Bva02g01813 | 313 | SUPERFAMILY | DNA-binding domain | 32 | 88 | IPR016177 | GO:0003677 | |
Bva02g01813 | 313 | MobiDBLite | consensus disorder prediction | 1 | 25 | - | - | |
Bva02g01813 | 313 | CDD | AP2 | 31 | 90 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | MobiDBLite | consensus disorder prediction | 83 | 107 | - | - | |
Bva02g01813 | 313 | ProSiteProfiles | AP2/ERF domain profile. | 31 | 88 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | Pfam | AP2 domain | 31 | 80 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | MobiDBLite | consensus disorder prediction | 11 | 25 | - | - | |
Bva02g01813 | 313 | MobiDBLite | consensus disorder prediction | 85 | 106 | - | - | |
Bva02g01813 | 313 | PANTHER | AP2 DOMAIN CLASS TRANSCRIPTION FACTOR | 1 | 258 | - | - | |
Bva02g01813 | 313 | PRINTS | Ethylene responsive element binding protein signature | 32 | 43 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | PRINTS | Ethylene responsive element binding protein signature | 54 | 70 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | SMART | rav1_2 | 31 | 94 | IPR001471 | GO:0003700|GO:0006355 | |
Bva02g01813 | 313 | Gene3D | AP2/ERF domain | 30 | 89 | IPR036955 | GO:0003700|GO:0006355 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Bva02g01813 | Bva-Chr2 | 20166250 | 20167191 | Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Bva02g01813 | 23 | 88 | AP2-EREBP Transcription Factor Family | AT5G19790 | 66.667 | 3.78e-26 | 102 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
TF | AP2/ERF-ERF | Bva02g01813 | AP2 | 1.1e-15 | CL0081 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Bva02g01813 | K09286 | - | gmx:100799444 | 295.049 |